Johnson K P, Panitch H S
Department of Neurology, University of Maryland School of Medicine, Baltimore.
Md Med J. 1992 Jul;41(7):601-3.
Laboratory findings that suppressor cell function is improved with beta interferon therapy and that gamma interferon activity is inhibited by beta interferon provide support for the hypothesis that beta interferon will have a significant therapeutic effect on relapse rates in multiple sclerosis.
实验室研究结果表明，β干扰素治疗可改善抑制性细胞功能，且β干扰素可抑制γ干扰素活性，这为β干扰素对多发性硬化症复发率具有显著治疗作用这一假说提供了支持。
